Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

7.36
Delayed Data
As of 3:59pm ET
 +0.88 / +13.58%
Today’s Change
5.59
Today|||52-Week Range
12.50
-18.22%
Year-to-Date
Company News for November 29, 2016
Nov 29 / Zacks.com - Paid Partner Content
Recro Pharma (REPH) in Focus: Stock Moves 19.8% Higher
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close6.48
Today’s open6.43
Day’s range6.43 - 7.59
Volume456,097
Average volume (3 months)131,073
Market cap$78.8M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,523.81%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales1.52
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
SPHSSophiris Bio Inc+0.18+6.84%
SBBPStrongbridge Biophar...-0.00-0.05%
IPCIIntellipharmaceutics...+0.09+3.32%
INNLInnocoll Holdings PL...-0.01-0.38%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$52.0M
Annual profit (last year)$3.0M
Net profit margin5.84%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts


Search for Jobs